Øystein Rekdal
Förmögenhet: 161 613 $ per 2026-07-31
Förmögenhet: 161 613 $ per 2026-07-31
Øystein Rekdal is the founder of Lytix Biopharma AS, serving as Chief Executive Officer & Media Relations Contact since 2019, founded in 2003.
Dr. Rekdal is a Professor at the University of Tromso.
Formerly, Dr. Rekdal worked as Director at Prophylix AS.
Education includes a doctorate from the University of Tromso.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
LYTIX BIOPHARMA ASA 0,23 % | 2025-12-11 | 176 179 ( 0,23 % ) | 161 613 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| LYTIX BIOPHARMA ASA | Verkställande Direktör | 2019-09-11 |
University of Tromso
University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
University of Tromso
University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån